ZARXIO
NDC 61314-318, filgrastim-sndz, injection, solution, from Sandoz Inc..
- Product NDC
- 61314-318
- Status
- Listed
- Labeler
- Sandoz Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125553
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61314-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM300 ug/.5mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61314-318-01 | 61314031801 | 1 BLISTER PACK in 1 CARTON (61314-318-01) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE |
| 61314-318-10 | 61314031810 | 2 BLISTER PACK in 1 CARTON (61314-318-10) / 5 SYRINGE in 1 BLISTER PACK (61314-318-05) / .5 mL in 1 SYRINGE |
| 61314-318-63 | 61314031863 | 1 BLISTER PACK in 1 CARTON (61314-318-63) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE |
| 61314-318-69 | 61314031869 | 2 BLISTER PACK in 1 CARTON (61314-318-69) / 5 SYRINGE in 1 BLISTER PACK (61314-318-65) / .5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c0d1c22b-566b-4776-bdbf-00f96dad0caeMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61314-318NADAC price for package 61314031801
GET /v1/drugs/nadac/61314031801
Use it
Look up 61314-318 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61314-318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61314-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.